ANCC Family Nurse Practitioner FNP Board Exam Actual
Exam 2026/2027 | Questions with Verified Answers |
100% Correct | Pass Guaranteed
SECTION 1: Health Promotion & Disease Prevention
Q1: A 52-year-old woman presents for a routine wellness visit. She has no personal
history of cardiovascular disease, breast cancer, or diabetes. Her BMI is 26 kg/m² and
her BP is 118/72 mmHg. She asks what screening tests she needs this year. According
to USPSTF 2026 guidelines, which screening is most appropriate to recommend now?
A. Lipid panel every 2 years
B. Mammography every 2 years
C. HbA1c annually
D. Coronary artery calcium score
Correct Answer: B
Rationale: USPSTF Grade B recommends biennial mammography for women aged
50–74 with average breast-cancer risk. Lipid screening (A) starts at 40 yrs for women
but is every 5 yrs if normal; HbA1c (C) is indicated starting at 35 yrs only if
overweight/obese (BMI ≥25) or with risk factors—this patient’s BMI is 26 but she lacks
other risk factors, so annual screening is not yet required. Coronary calcium scoring (D)
is not a USPSTF-recommended screening tool for asymptomatic low-risk adults.
Q2: A 16-year-old male is seen for a pre-participation sports physical. He received Tdap
at age 11 and completed the primary IPV, MMR, and varicella series. Which
immunization is indicated today?
A. Meningococcal ACWY booster
,B. HPV 9-valent first dose
C. Second varicella dose
D. Pneumococcal polysaccharide vaccine
Correct Answer: A
Rationale: CDC 2026 adolescent schedule advises a single meningococcal ACWY
booster at age 16 if the primary dose was given at 11–12 yrs. HPV series (B) should
have started at 11–12 yrs; if not given, start now—but the question asks what is
“indicated today” based on current evidence, and the booster is time-sensitive. Varicella
(C) series is complete; PCV15/23 (D) is not indicated in healthy teens.
Q3: A 24-year-old G0 presents for a well-woman visit. She is sexually active with one
male partner and uses condoms inconsistently. She denies prior cervical cytology
abnormalities. When should she begin cervical cancer screening?
A. Begin now with primary HPV test every 5 years
B. Begin at age 25 with cytology every 3 years
C. Begin at age 30 with co-testing every 5 years
D. Begin now with annual cytology until age 30
Correct Answer: B
Rationale: USPSTF & ASCCP 2026 guidance: start cervical screening at age 25
regardless of sexual history, with primary cytology every 3 yrs or primary HPV every 5
yrs. Option A is acceptable only ≥25 yrs; C delays unnecessarily; D recommends an
outdated annual interval.
, Q4: A 6-month-old infant is brought to the clinic for routine vaccination. Her vaccine
record shows: HepB (birth, 2 mos, 4 mos); RV (2, 4 mos); DTaP (2, 4 mos); Hib (2, 4
mos); PCV15 (2, 4 mos); IPV (2, 4 mos). Which vaccine is indicated today?
A. IPV #3
B. HepB #4
C. MMR #1
D. Varicella #1
Correct Answer: A
Rationale: IPV #3 is due at 6 months (minimum 24 weeks). HepB series is complete
after 3 doses; MMR and varicella start at 12 months.
Q5: A 45-year-old African-American man presents for a wellness visit. His BMI is 24
kg/m², BP 128/78 mmHg, no family history of diabetes. According to USPSTF 2026,
screening for type 2 diabetes should begin:
A. Immediately with HbA1c every 3 years
B. At age 50 with fasting glucose every 3 years
C. At age 35 with HbA1c every 3 years
D. At age 40 with 2-hr OGTT every 5 years
Correct Answer: C
Rationale: USPSTF Grade B screening starts at age 35 yrs for adults with
overweight/obese (BMI ≥25 kg/m²) OR any risk factor (race/ethnicity, FHx, HTN, etc.).
African-American race is an independent risk factor; thus screening begins now (age
45) with HbA1c, fasting glucose, or 2-hr OGTT every 3 yrs. Option C interval is correct
even though age 35 is earlier; starting at 50 (B) or 40 (D) delays evidence-based
screening.
Exam 2026/2027 | Questions with Verified Answers |
100% Correct | Pass Guaranteed
SECTION 1: Health Promotion & Disease Prevention
Q1: A 52-year-old woman presents for a routine wellness visit. She has no personal
history of cardiovascular disease, breast cancer, or diabetes. Her BMI is 26 kg/m² and
her BP is 118/72 mmHg. She asks what screening tests she needs this year. According
to USPSTF 2026 guidelines, which screening is most appropriate to recommend now?
A. Lipid panel every 2 years
B. Mammography every 2 years
C. HbA1c annually
D. Coronary artery calcium score
Correct Answer: B
Rationale: USPSTF Grade B recommends biennial mammography for women aged
50–74 with average breast-cancer risk. Lipid screening (A) starts at 40 yrs for women
but is every 5 yrs if normal; HbA1c (C) is indicated starting at 35 yrs only if
overweight/obese (BMI ≥25) or with risk factors—this patient’s BMI is 26 but she lacks
other risk factors, so annual screening is not yet required. Coronary calcium scoring (D)
is not a USPSTF-recommended screening tool for asymptomatic low-risk adults.
Q2: A 16-year-old male is seen for a pre-participation sports physical. He received Tdap
at age 11 and completed the primary IPV, MMR, and varicella series. Which
immunization is indicated today?
A. Meningococcal ACWY booster
,B. HPV 9-valent first dose
C. Second varicella dose
D. Pneumococcal polysaccharide vaccine
Correct Answer: A
Rationale: CDC 2026 adolescent schedule advises a single meningococcal ACWY
booster at age 16 if the primary dose was given at 11–12 yrs. HPV series (B) should
have started at 11–12 yrs; if not given, start now—but the question asks what is
“indicated today” based on current evidence, and the booster is time-sensitive. Varicella
(C) series is complete; PCV15/23 (D) is not indicated in healthy teens.
Q3: A 24-year-old G0 presents for a well-woman visit. She is sexually active with one
male partner and uses condoms inconsistently. She denies prior cervical cytology
abnormalities. When should she begin cervical cancer screening?
A. Begin now with primary HPV test every 5 years
B. Begin at age 25 with cytology every 3 years
C. Begin at age 30 with co-testing every 5 years
D. Begin now with annual cytology until age 30
Correct Answer: B
Rationale: USPSTF & ASCCP 2026 guidance: start cervical screening at age 25
regardless of sexual history, with primary cytology every 3 yrs or primary HPV every 5
yrs. Option A is acceptable only ≥25 yrs; C delays unnecessarily; D recommends an
outdated annual interval.
, Q4: A 6-month-old infant is brought to the clinic for routine vaccination. Her vaccine
record shows: HepB (birth, 2 mos, 4 mos); RV (2, 4 mos); DTaP (2, 4 mos); Hib (2, 4
mos); PCV15 (2, 4 mos); IPV (2, 4 mos). Which vaccine is indicated today?
A. IPV #3
B. HepB #4
C. MMR #1
D. Varicella #1
Correct Answer: A
Rationale: IPV #3 is due at 6 months (minimum 24 weeks). HepB series is complete
after 3 doses; MMR and varicella start at 12 months.
Q5: A 45-year-old African-American man presents for a wellness visit. His BMI is 24
kg/m², BP 128/78 mmHg, no family history of diabetes. According to USPSTF 2026,
screening for type 2 diabetes should begin:
A. Immediately with HbA1c every 3 years
B. At age 50 with fasting glucose every 3 years
C. At age 35 with HbA1c every 3 years
D. At age 40 with 2-hr OGTT every 5 years
Correct Answer: C
Rationale: USPSTF Grade B screening starts at age 35 yrs for adults with
overweight/obese (BMI ≥25 kg/m²) OR any risk factor (race/ethnicity, FHx, HTN, etc.).
African-American race is an independent risk factor; thus screening begins now (age
45) with HbA1c, fasting glucose, or 2-hr OGTT every 3 yrs. Option C interval is correct
even though age 35 is earlier; starting at 50 (B) or 40 (D) delays evidence-based
screening.
